RTO deadline alert: Rosen, a leading national firm, encourages initial investors in Renokil to secure advisors before the important Jan. 27 deadline in the securities class action

New York, New York -(Newsfile Corp. -January 25, 2025) – WHY: The Rosen Law Firm, a global investor rights law firm, reminds buyers of American Depositary Shares (“Ads”) Renokil initial PLC (NYSE: LON 🙂 between December 1, 2023 and September 10, 2024, both dates inclusive (“Class Period”), the relevant January 27, 2025, the main prosecution deadline.

So what: If you purchased Renokil ADSs during the class period, you may be entitled to compensation without paying any out-of-pocket compensation or expenses through a contingency compensation arrangement.

What next: To join the Renokil class action, go to https://rosengegal.com/submit-form/?case_id=31778 or call Phillip Kim, Esq. Toll free at 866-767-3653 or email case@rosenlegal.com for class action information. A class action lawsuit has already been filed. If you want to serve as the chief prosecutor, you have to move the court no later than January 27, 2025. The lead plaintiff is the representative party who acts on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select a qualified advisor with a track record of leadership. Often the firms issuing the notices do not have comparable experience, resources or any significant peer recognition. Many of these firms do not actually pair securities class actions, but are merely brokers who relate to clients or partner with the law firms that actually litigate the cases. Be wise in choosing your advice. The Rosen Law Firm represents investors worldwide, concentrating its practice in securities class actions and shareholder derivative litigation. The Rosen Law Firm achieved the largest class action settlement ever at that time. Law firm Rosen ranked 1st in ISS Securities Action (WA 🙂 Services for the number of securities action settlements in 2017. The company has been ranked in the top 4 every year since 2013 and has accounted for hundreds of millions of dollars for investors. In 2019 alone, the company secured more than $438 million for investors. In 2020, founder Laurence Rosen was named a titan of plaintiffs by Law360. Many of the firm’s lawyers have been recognized by Lawdragon and Super Lawyers.

Case details: According to the lawsuit, the defendants made false and/or misleading statements and/or failed to disclose that: (1) renokil experienced a level of disruption in the early Terminix integration pilots; (2) Renokil experienced significant, ongoing, self-inflicted execution challenges integrating terminix; (3) Disruption and execution challenges inflated Redokil’s integration plan for Terminix; (4) Redokil and Terminix are still two separate companies that have not yet been integrated; (5) Redokil’s failure to integrate Terminix adversely affected Redokil’s business and operations, particularly organic revenue growth in North America; and (6) as a result of the foregoing, Defendants’ positive statements about the business, operations and prospects of Renokil were materially false and misleading and/or lacked reasonable basis at all relevant times. When the true details entered the market, the lawsuit alleges, investors were harmed.

To join the Renokil class action, go to https://rosengegal.com/submit-form/?case_id=31778 or call Phillip Kim, Esq. Toll free at 866-767-3653 or email case@rosenlegal.com for class action information.

No classes are certified. Until the class is certified, the attorney does not represent you if you do not retain it. You can choose the advice of your choice. You can also remain an absent member of the class and do nothing at this time. The investor’s ability to share in any potential future recovery is not dependent on the service of the lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ :): https:/ /www.facebook.com/rosenlawfirm.

Advertising of lawyers. Previous results do not guarantee a similar outcome.

————————–

To view the original version of this press release, please visit https://www.newsfilecorp.com/release/238322